HIV-1 acute infection: evidence for selection?
|
|
- Marvin Gardner
- 5 years ago
- Views:
Transcription
1 HIV-1 acute infection: evidence for selection? ROLLAND Morgane University of Washington
2 Cohort & data S6 S5 T4 S4 T2 S2 T1 S1 S7 T3 DPS (days post symptoms) 3 (Fiebig I) 7 (Fiebig I) 13 (Fiebig V) 14 (Fiebig I) 3 (Fiebig I) 8 (Fiebig I) 3 (Fiebig I) Eleven HIV-1 subtype B infected individuals from the Seattle Primary Infection Cohort (SeaPIC) Near full length genomes (~9,1 Kb) were amplified from plasma by singletemplate PCR, cloned and sequenced 495 HIV-1 subtype B genomes Eight individuals were enrolled during acute HIV-1 infection Four transmission pairs 25 (Fiebig V) HXB2 acute infection
3 A single founder variant typically establishes HIV-1 infection S5 T2 S2 Phylogenetic tree with sequences from the first time point after infection in recipients: A single HIV-1 variant established infection in 8 of the 9 MSM HXB2 S6 T1 Li et al. PLoS Pathogens S1 S7 S4 T4 T3 MSM: 31/50 = 62% HSX: 141/175 subjects = 81% (p = 0.008) Other MSM cohorts: 77% of 64 Step vaccine trial volunteers infected with subtype B (Rolland, Stovanabutra, decamp et al., submitted) 86% of 37 MSM evaluated preseroconversion in the MACS cohort (Gottlieb et al., 2008)
4 Comparison of sequences from transmission pairs HXB2 S2, sampled at 3 dps Sample from T2 on same day, sampled at 25 dps Sample from T3 8 days later S4, sampled at 13 dps Sample from T4 10 days later S1, sampled at 8 dps Sample from T1 17 days later S1 S2 T2, 14 dps S4 T3, 9 yrs T4, 9 yrs T1, 10 yrs Restriction to a single founder not due to lack of variation in transmitter Comparison between the genome sequences from the transmitter and genomes from visit 1 in the recipient No exact match at the genome level; exact match in gag or pol Closest match: : 98.31% identity to a genome from T3 S4: 98.89% identity to a genome from T4 S1: 99.28% identity to a genome from T1 S2: 99.82% identity to a genome from T2
5 Comparison to the consensus from the transmitter S2, sampled at 3 dps Sample from T2 on same day S2 T2, 14 dps T3, 9 yrs Divergence from transmitter consensus p = 0.84, sampled at 25 dps Sample from T3 8 days later T2 S2 S4, sampled at 13 dps Sample from T4 10 days later S T3 p = T4, 9 yrs S1, sampled at 8 dps Sample from T1 17 days later S T S4 p = 0.68 T1, 10 yrs HXB2 Consensus from transmitter sequences T S1 p = 0.58
6 Comparison to the consensus from the transmitter Divergence from transmitter consensus T T3 p = T T1 p = S2 p = S4 p = S1 The founder variant: did not correspond to the consensus from the transmitter seemed to be a rare variant in the transmitter, that nonetheless was within the distribution of variants found in the transmitter, except in the case of. The genomes from were significantly more divergent than any genome in the transmitter. Lack of exact match can be due to: Insufficient or non-simultaneous sampling Compartmentalization: plasma vs semen Selection for viruses better adapted to the new host
7 ELISpot assays with transmitter- and recipient-specific peptides Predicted epitopes Forward mutation Decrease in database frequency by >50% between: 1) the AA in the transmitter and the AA in the recipient 2) the consensus AA in the recipient and the mutated AA Reverse mutation Increase in database frequency by >50% ELISpot responses assays Hypothesis: Sites that differ between transmitter and recipient may correspond to sites under CTL pressure in the transmitter, that reverted back to a consensus-like form upon transmission to a new host One example of a CTL response directed against a Nef region in the transmitter
8 Longitudinal follow-up Follow-up between: S6 3 and 350 dps, 12 visits 123 genomes S5 7 and 181 dps, 8 visits 85 genomes T4, S4 HXB2 T2, S2 T1, S1 S7 T3 3 and 196 dps, 7 visits, 68 genomes 25 and 247 dps, 9 visits, 93 genomes
9 Diversification over time Pairwise diversity, genomes dps Rate of diversification, % per year genome S5 S6 S7 gag pol env, C2V5 nef The rate of evolution varied across the genome; it was higher in env and nef. The rates seen in C2V5 are comparable to the rates reported in chronic infection (0.92%+/-0.29, Shankarappa et al., 1999)
10 A dip in nucleotide diversity in acute infection Pairwise diversity, based on genomes, normalized to zero at visit 1 S6 S7 S dps The pairwise nucleotide diversity decreased in the earliest time points of infection.
11 A dip in APOBEC3G-mediated mutations APOBEC3G S6 APOBEC3G diversity S7 Pairwise diversity, genomes Control G>A mutations S5 Diversity in S6 Diversity in S5 Diversity in S7 Diversity in APOBEC3G dps Control G>A mutations The dip in APOBEC3G-mediated mutations was parallel to the dip in nucleotide diversity Yet, the dip in APOBEC3G-induced mutations was not the cause of the dip in nucleotide diversity.
12 Demographic processes dominate in acute infection Viral loads (x100,000) Viral loads S6 S7 Pairwise diversity, genomes Diversity Significant deviations in neutrality tests S5 Diversity in S6 Diversity in S5 Diversity in S7 Diversity in At the genome level, neutrality tests (Tajima s D and Fu and Li s D*) showed negative deviations from the neutral model, suggesting alternative hypotheses, such as selection or demographic history: founder effects, changes in population size or purifying selection can lead to strong negative deviations. Genome-wide and gene-specific tests were congruent, thus showing the predominance of demographic processes in acute infection. The dip in diversity is likely due to the single variant-founder effect and the subsequent delay before the viral population reaches equilibrium dps
13 Signs of selection appear at 1-2 weeks post symptoms The earliest fixation of an AA substitution occurred at day 21 in Tat (S5) By 6 months post-infection, there were between 9 (in S6) and 18 (in S7) positively selected sites across the genome. Mutually-exclusive substitution patterns in predicted CTL epitopes More evidence of forward ( escape ) than reverse mutations: S7: 37 forward vs. 2 reverse mutations S5: 53 forward vs. 7 reverse mutations S6: 91 forward vs. 7 reverse mutations : 55 forward vs. 10 reverse mutations X X Forward mutation Reverse mutation
14 Conclusion HIV-1 acute infection is characterized by a founder effect with single variants establishing infection in 81 % of individuals (based on 110 MSM) The variants establishing infection in the recipient did not correspond to the consensus variant in the transmitter. Demographic processes dominated in the earliest weeks of infection Founder effect (short branch lengths to the MRCA) and multiplicity of variable sites (star-like phylogeny) led to significant negative deviations from the neutral model. Across transmission pairs and over time in the recipients, we found more evidence of forward ( escape ) than reverse mutations Mutually-exclusive substitution patterns in predicted CTL epitopes
15 Acknowledgments James I. Mullins Joshua T. Herbeck Seattle Primary Infection Cohort Yi Liu Sherry McLaughlin Hong Zhao Kim Wong Julia N. Stoddard Dana Raugi Stephanie Sorensen Indira Genowati Brian Birditt Angela McKay Brandon S. Maust Wenjie Deng M. Juliana McElrath John McNevin Nicole Frahm Justine E. Brown Kurt Diem Joanne D. Stekler Ann C. Collier
Demographic Processes Affect HIV-1 Evolution in Primary Infection before the Onset of Selective Processes
JOURNAL OF VIROLOGY, Aug. 2011, p. 7523 7534 Vol. 85, No. 15 0022-538X/11/$12.00 doi:10.1128/jvi.02697-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. Demographic Processes Affect
More informationGenetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial
CORRECTION NOTICE Nat. Med. 17, 366 371 (2011) Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial Morgane Rolland, Sodsai Tovanabutra, Allan C decamp, Nicole Frahm, Peter
More informationChronic HIV-1 Infection Frequently Fails to Protect against Superinfection
Chronic HIV-1 Infection Frequently Fails to Protect against Superinfection Anne Piantadosi 1,2[, Bhavna Chohan 1,2[, Vrasha Chohan 3, R. Scott McClelland 3,4,5, Julie Overbaugh 1,2* 1 Division of Human
More informationSelection on the Human Immunodeficiency Virus Type 1 Proteome following Primary Infection
JOURNAL OF VIROLOGY, Oct. 2006, p. 9519 9529 Vol. 80, No. 19 0022-538X/06/$08.00 0 doi:10.1128/jvi.00575-06 Copyright 2006, American Society for Microbiology. All Rights Reserved. Selection on the Human
More informationOn an individual level. Time since infection. NEJM, April HIV-1 evolution in response to immune selection pressures
HIV-1 evolution in response to immune selection pressures BISC 441 guest lecture Zabrina Brumme, Ph.D. Assistant Professor, Faculty of Health Sciences Simon Fraser University http://www3.niaid.nih.gov/topics/hivaids/understanding/biology/structure.htm
More informationUnderstanding HIV. Transmitted/Founder Viruses. Brandon Keele SAIC-Frederick National Cancer Institute
Understanding HIV Transmission Utilizing Transmitted/Founder Viruses Brandon Keele SAIC-Frederick National Cancer Institute AIDS Vaccine 2011 15 September 2011 Overview Several years ago, the CHAVI sought
More informationHIV-1 Dual Infection and Neurocognitive Impairment
HIV-1 Dual Infection and Neurocognitive Impairment Gabriel Wagner, MD Assistant Professor of Medicine Infectious Diseases & Global Public Health UC San Diego HIV-Associated End Organ Damage Antiretroviral
More informationHow HIV Causes Disease Prof. Bruce D. Walker
How HIV Causes Disease Howard Hughes Medical Institute Massachusetts General Hospital Harvard Medical School 1 The global AIDS crisis 60 million infections 20 million deaths 2 3 The screen versions of
More informationTransmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients
Transmitted Virus Fitness and Host T Cell Responses Collectively Define Divergent Infection Outcomes in Two HIV-1 Recipients Ling Yue, Emory University Katja J. Pfafferott, University of Oxford Joshua
More informationEvolution of influenza
Evolution of influenza Today: 1. Global health impact of flu - why should we care? 2. - what are the components of the virus and how do they change? 3. Where does influenza come from? - are there animal
More informationReliable reconstruction of HIV-1 whole genome haplotypes reveals clonal interference and genetic hitchhiking among immune escape variants
Pandit and de Boer Retrovirology 2014, 11:56 RESEARCH Open Access Reliable reconstruction of HIV-1 whole genome haplotypes reveals clonal interference and genetic hitchhiking among immune escape variants
More informationCitation for published version (APA): Von Eije, K. J. (2009). RNAi based gene therapy for HIV-1, from bench to bedside
UvA-DARE (Digital Academic Repository) RNAi based gene therapy for HIV-1, from bench to bedside Von Eije, K.J. Link to publication Citation for published version (APA): Von Eije, K. J. (2009). RNAi based
More informationHigher priming doses enhance HIV-specific humoral but not cellular. responses in a randomized, double-blind phase Ib clinical trial of
Higher priming doses enhance HIV-specific humoral but not cellular responses in a randomized, double-blind phase Ib clinical trial of preventive HIV-1 vaccines Pierre-Alexandre Bart a,b, Yunda Huang c,
More informationHIV Diversity in East Africa
HIV Diversity in East Africa Kayvon Modjarrad, M.D., Ph.D. 16 March 2015 The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army or the Department
More informationFrequency and Dynamics of Transmitted Polymorphisms and their Impact on Early Pathogenesis in Heterosexual Couples in Zambia
Frequency and Dynamics of Transmitted Polymorphisms and their Impact on Early Pathogenesis in Heterosexual Couples in Zambia 8 th International Workshop on HIV Transmission Principles of Intervention Barcelona,
More informationWithin-host and between-host evolutionary rates across the HIV-1 genome
Alizon and Fraser Retrovirology 2013, 10:49 RESEARCH Open Access Within-host and between-host evolutionary rates across the HIV-1 genome Samuel Alizon 1* and Christophe Fraser 2 Abstract Background: HIV
More informationHOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS
HOST-PATHOGEN CO-EVOLUTION THROUGH HIV-1 WHOLE GENOME ANALYSIS Somda&a Sinha Indian Institute of Science, Education & Research Mohali, INDIA International Visiting Research Fellow, Peter Wall Institute
More informationA new wild-type in the era of transmitted drug resistance
A new wild-type in the era of transmitted drug resistance EHR 2018 Rome KU Leuven 1 A new wild-type in the era of transmitted drug resistance? KU Leuven 2 Measurably evolving viruses Evolutionary rate
More informationAn Analysis of Genital Tract Derived HIV from Heterosexual Transmission Pairs. Debrah Boeras Emory University October 14, 2008
An Analysis of Genital Tract Derived HIV from Heterosexual Transmission Pairs Debrah Boeras Emory University October 14, 2008 Background A majority of HIV-1 infections occur through heterosexual exposure
More informationGoing Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution.
Going Nowhere Fast: Lentivirus genetic sequence evolution does not correlate with phenotypic evolution. Brian T. Foley, PhD btf@lanl.gov HIV Genetic Sequences, Immunology, Drug Resistance and Vaccine Trials
More informationNK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections
NK mediated Antibody Dependent Cellular Cytotoxicity in HIV infections Amy Chung Dr. Ivan Stratov Prof. Stephen Kent ADCC process consists of Target cell QuickTime and a TIFF (Uncompressed) FcγR decompressor
More informationHIV acute infections and elite controllers- what can we learn?
HIV acute infections and elite controllers- what can we learn? Thumbi Ndung u, BVM, PhD KwaZulu-Natal Research Institute for Tuberculosis and HIV (K-RITH) and HIV Pathogenesis Programme (HPP), Doris Duke
More informationInnate and Cellular Immunology Control of Infection by Cell-mediated Immunity
Innate & adaptive Immunity Innate and Cellular Immunology Control of Infection by Cell-mediated Immunity Helen Horton PhD Seattle Biomedical Research Institute Depts of Global Health & Medicine, UW Cellular
More informationCharacterizing intra-host influenza virus populations to predict emergence
Characterizing intra-host influenza virus populations to predict emergence June 12, 2012 Forum on Microbial Threats Washington, DC Elodie Ghedin Center for Vaccine Research Dept. Computational & Systems
More informationSupplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR
Supplemental Materials and Methods Plasmids and viruses To generate pseudotyped viruses, the previously described recombinant plasmids pnl4-3-δnef-gfp or pnl4-3-δ6-drgfp and a vector expressing HIV-1 X4
More informationMina John Institute for Immunology and Infectious Diseases Royal Perth Hospital & Murdoch University Perth, Australia
Mina John Institute for Immunology and Infectious Diseases Royal Perth Hospital & Murdoch University Perth, Australia AIDSvaccine conference, 14 th September 2011 IMGT HLA database July 2011 >5000 class
More informationT cell Vaccine Strategies for HIV, the Virus. With a Thousand Faces
JVI Accepts, published online ahead of print on 13 May 2009 J. Virol. doi:10.1128/jvi.00114-09 Copyright 2009, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
More informationHIV Life Cycle & Genetics
HIV Life Cycle & enetics! etroviruses (and transposable elements) appear to be part of every cell's genome! From bacteria to yeast, flies, fish, and humans! ome endogenous retroviruses (most notably in
More informationPrevention of infection 2 : immunisation. How infection influences the host : viruses. Peter
Prevention of infection 2 : immunisation How infection influences the host : viruses Peter Balfe, p.balfe@bham.ac.uk @pbalfeuk Let s have some LO s just for fun 1. Define the Immune response to viruses,
More informationSearch for the Mechanism of Genetic Variation in the pro Gene of Human Immunodeficiency Virus
JOURNAL OF VIROLOGY, Oct. 1999, p. 8167 8178 Vol. 73, No. 10 0022-538X/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Search for the Mechanism of Genetic Variation
More informationMultiple sequence alignment
Multiple sequence alignment Bas. Dutilh Systems Biology: Bioinformatic Data Analysis Utrecht University, February 18 th 2016 Protein alignments We have seen how to create a pairwise alignment of two sequences
More informationPopulation-level Immune-mediated Adaptation in HIV-1 Polymerase during the North American Epidemic
JVI Accepted Manuscript Posted Online 11 November 2015 J. Virol. doi:10.1128/jvi.02353-15 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
More informationRajesh Kannangai Phone: ; Fax: ; *Corresponding author
Amino acid sequence divergence of Tat protein (exon1) of subtype B and C HIV-1 strains: Does it have implications for vaccine development? Abraham Joseph Kandathil 1, Rajesh Kannangai 1, *, Oriapadickal
More informationEmerging Diseases. Biosciences in the 21 st Century Dr. Amber Rice October 26, 2012
Emerging Diseases Biosciences in the 21 st Century Dr. Amber Rice October 26, 2012 Outline Disease emergence: a case study Introduction to phylogenetic trees Introduction to natural selection How do pathogens
More informationImpact of Mutations in Highly Conserved Amino Acids of the HIV-1 Gag-p24 and Env-gp120 Proteins on Viral Replication in Different Genetic Backgrounds
Impact of Mutations in Highly Conserved Amino Acids of the HIV-1 Gag-p24 and Env-gp120 Proteins on Viral Replication in Different Genetic Backgrounds Yi Liu 1 *, Ushnal Rao 1, Jan McClure 1, Philip Konopa
More informationRAISON D ETRE OF THE IMMUNE SYSTEM:
RAISON D ETRE OF THE IMMUNE SYSTEM: To Distinguish Self from Non-Self Thereby Protecting Us From Our Hostile Environment. Innate Immunity Adaptive Immunity Innate immunity: (Antigen - nonspecific) defense
More informationLecture 11. Immunology and disease: parasite antigenic diversity
Lecture 11 Immunology and disease: parasite antigenic diversity RNAi interference video and tutorial (you are responsible for this material, so check it out.) http://www.pbs.org/wgbh/nova/sciencenow/3210/02.html
More informationWhole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection
Whole Genome Deep Sequencing of HIV-1 Reveals the Impact of Early Minor Variants Upon Immune Recognition During Acute Infection The Harvard community has made this article openly available. Please share
More informationThe first T cell response to transmitted/ founder virus contributes to the control of acute viremia in HIV-1 infection
Published Online: 1 June, 2009 Supp Info: http://doi.org/10.1084/jem.20090365 Downloaded from jem.rupress.org on December 10, 2018 ARTICLE The first T cell response to transmitted/ founder virus contributes
More informationDeveloping Understanding of CMI. Dr Tom Wilkinson Associate Professor of Respiratory Medicine Faculty of Medicine University of Southampton UK
Pre-existing influenza-specific CD4+ T cells correlate with homologous and heterotypic response and disease protection against influenza challenge in humans Do At Risk Groups Rely more on CMI to Viruses?
More informationOriginally published as:
Originally published as: Ratsch, B.A., Bock, C.-T. Viral evolution in chronic hepatitis B: A branched way to HBeAg seroconversion and disease progression? (2013) Gut, 62 (9), pp. 1242-1243. DOI: 10.1136/gutjnl-2012-303681
More informationReceived 9 October 2008/Accepted 24 December 2008
JOURNAL OF VIROLOGY, Apr. 2009, p. 3556 3567 Vol. 83, No. 8 0022-538X/09/$08.00 0 doi:10.1128/jvi.02132-08 Copyright 2009, American Society for Microbiology. All Rights Reserved. Quantitating the Multiplicity
More informationCOMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN GP160 PROTEIN OF HIV TYPE-1
Journal of Cell and Tissue Research Vol. 10(3) 2359-2364 (2010) ISSN: 0973-0028 (Available online at www.tcrjournals.com) Original Article COMPUTATIONAL ANALYSIS OF CONSERVED AND MUTATED AMINO ACIDS IN
More informationarxiv: v1 [q-bio.pe] 8 Sep 2015
Population genomics of intrapatient HIV-1 evolution Fabio Zanini 1, Johanna Brodin 2, Lina Thebo 2, Christa Lanz 1, Göran Bratt 4, Jan Albert 2,3 and Richard A. Neher 1 1 Evolutionary Dynamics and Biophysics,
More informationRAISON D ETRE OF THE IMMUNE SYSTEM:
RAISON D ETRE OF THE IMMUNE SYSTEM: To Distinguish Self from Non-Self Thereby Protecting Us From Our Hostile Environment. Innate Immunity Acquired Immunity Innate immunity: (Antigen nonspecific) defense
More informationHost Genomics of HIV-1
4 th International Workshop on HIV & Aging Host Genomics of HIV-1 Paul McLaren École Polytechnique Fédérale de Lausanne - EPFL Lausanne, Switzerland paul.mclaren@epfl.ch Complex trait genetics Phenotypic
More informationEbola Virus. Emerging Diseases. Biosciences in the 21 st Century Dr. Amber Rice December 4, 2017
Ebola Virus Emerging Diseases Biosciences in the 21 st Century Dr. Amber Rice December 4, 2017 Outline Disease emergence: a case study How do pathogens shift hosts? Evolution within hosts: The evolution
More informationTransmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection
Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection The Harvard community has made this article openly available. Please share how this access benefits you. Your story
More informationHIV-1 subtype C in Karonga District, Malawi. Simon Travers
HIV-1 subtype C in Karonga District, Malawi Simon Travers HIV-1; closely related to HIV found in chimps HIV-2; closely related to HIV found in mangabys Worldwide Distribution of HIV-1 group M subtypes
More informationHVTN Laboratory Program: Immunogenicity and Research Assays
HVTN Laboratory Program: Immunogenicity and Research Assays Erica Andersen-Nissen, PhD Director, Cape Town HVTN Immunology Laboratory Considerations for a Pan-African HIV Vaccine Development Agenda Kigali,
More informationMRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load
MRKAd5 HIV-1 Gag/Pol/Nef Vaccine-Induced T-Cell Responses Inadequately Predict Distance of Breakthrough HIV-1 Sequences to the Vaccine or Viral Load Holly Janes 1,2 *, Nicole Frahm 1,3, Allan DeCamp 1,
More informationPhylogenetic Analysis of HIV Samples from a Single Host
Phylogenetic Analysis of HIV Samples from a Single Host Master Thesis Rounak Vyas November 20, 2011 Advisors: Prof. Niko Beerenwinkel, Dr. Osvaldo Zagordi Computational Biology Group, ETH Zürich Contents
More informationEvidence of Differential HLA Class I- Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1
Evidence of Differential HLA Class I- Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 The Harvard community has made this article openly available. Please share how this
More informationHIV-1 Subtypes: An Overview. Anna Maria Geretti Royal Free Hospital
HIV-1 Subtypes: An Overview Anna Maria Geretti Royal Free Hospital Group M Subtypes A (1, 2, 3) B C D F (1, 2) G H J K Mechanisms of HIV-1 genetic diversification Point mutations RT error rate: ~1 per
More informationModeling the Antigenic Evolution of Influenza Viruses from Sequences
Modeling the Antigenic Evolution of Influenza Viruses from Sequences Taijiao Jiang Center of Systems Medicine, Chinese Academy of Medical Sciences Suzhou Institute of Systems Medicine October 8-10, 2015.
More informationHIV-1 adaptation to HLA: a window into virus-host immune interactions
HIV-1 adaptation to HLA: a window into virus-host immune interactions Jonathan M. Carlson 1, Anh Q. Le 2, Aniqa Shahid 2, and Zabrina L. Brumme 2,3 1. Microsoft Research, Redmond, WA, USA 2. Faculty of
More informationEpitope discovery and Rational vaccine design Morten Nielsen
Epitope discovery and Rational vaccine design Morten Nielsen mniel@cbs.dtu.dk Bioinformatics in a nutshell List of peptides that have a given biological feature Mathematical model (neural network, hidden
More informationDEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED
DEBATE ON HIV ENVELOPE AS A T CELL IMMUNOGEN HAS BEEN GAG-GED Viv Peut Kent Laboratory, University of Melbourne, Australia WHY ENVELOPE? Env subject to both humoral and cellular immune responses Perhaps
More informationThe molecular clock of HIV-1 unveiled through analysis of a known transmission history
Proc. Natl. Acad. Sci. USA Vol. 96, pp. 10752 10757, September 1999 Evolution The molecular clock of HIV-1 unveiled through analysis of a known transmission history THOMAS LEITNER, AND JAN ALBERT Theoretical
More informationThe Swarm: Causes and consequences of HIV quasispecies diversity
The Swarm: Causes and consequences of HIV quasispecies diversity Julian Wolfson Dept. of Biostatistics - Biology Project August 14, 2008 Mutation, mutation, mutation Success of HIV largely due to its ability
More informationThe Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates
The Genealogical Population Dynamics of HIV-1 in a Large Transmission Chain: Bridging within and among Host Evolutionary Rates Bram Vrancken 1 *, Andrew Rambaut 2,3, Marc A. Suchard 4,5,6, Alexei Drummond
More informationTransmission Fitness of Drug- Resistant HIV Revealed in the United States National Surveillance System
Transmission Fitness of Drug- Resistant HIV Revealed in the United States National Surveillance System Joel O. Wertheim 1,2, Alexandra M. Oster 3, Jeffrey A. Johnson 3, William M. Switzer 3, Neeraja Saduvala
More informationTracing HIV 1 transmission: envelope traits of HIV 1 transmitter and recipient pairs
DOI 10.1186/s12977-016-0299-0 Retrovirology RESEARCH Open Access Tracing HIV 1 transmission: envelope traits of HIV 1 transmitter and recipient pairs Corinna S. Oberle 1,2, Beda Joos 1,2, Peter Rusert
More informationHHS Public Access Author manuscript Nat Med. Author manuscript; available in PMC 2016 November 16.
HHS Public Access Author manuscript Published in final edited form as: Nat Med. 2016 June ; 22(6): 606 613. doi:10.1038/nm.4100. Impact of Pre-adapted HIV Transmission Jonathan M. Carlson 1, Victor Y.
More informationSupplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood
Supplementary Figure 1. ALVAC-protein vaccines and macaque immunization. (A) Maximum likelihood tree illustrating CRF01_AE gp120 protein sequence relationships between 107 Envs sampled in the RV144 trial
More information(ii) The effective population size may be lower than expected due to variability between individuals in infectiousness.
Supplementary methods Details of timepoints Caió sequences were derived from: HIV-2 gag (n = 86) 16 sequences from 1996, 10 from 2003, 45 from 2006, 13 from 2007 and two from 2008. HIV-2 env (n = 70) 21
More informationDevelopment of a Universal T Cell Vaccine. Tomáš Hanke Weatherall Institute of Molecular Medicine University of Oxford United Kingdom
Development of a Universal T Cell Vaccine Tomáš Hanke Weatherall Institute of Molecular Medicine University of Oxford United Kingdom Development of HIV-1 vaccines Induction of cell-mediated responses Immunogens
More informationHIV and drug resistance Simon Collins UK-CAB 1 May 2009
HIV and drug resistance Simon Collins UK-CAB 1 May 2009 slides: thanks to Prof Clive Loveday, Intl. Clinical Virology Centre www.icvc.org.uk Tip of the iceberg = HIV result, CD4, VL Introduction: resistance
More informationLow-Dose Rectal Inoculation of Rhesus Macaques by SIVsmE660 or SIVmac251 Recapitulates Human Mucosal Infection by HIV-1
Low-Dose Rectal Inoculation of Rhesus Macaques by SIVsmE660 or SIVmac251 Recapitulates Human Mucosal Infection by HIV-1 The Harvard community has made this article openly available. Please share how this
More informationMID-TERM EXAMINATION
Epidemiology 227 May 2, 2007 MID-TERM EXAMINATION Select the best answer for the multiple choice questions. There are 75 questions and 11 pages on the examination. Each question will count one point. Notify
More informationSuperior Control of HIV-1 Replication by CD8+ T Cells Targeting Conserved Epitopes: Implications for HIV Vaccine Design
Superior Control of HIV-1 Replication by CD8+ T Cells Targeting Conserved Epitopes: Implications for HIV Vaccine Design Pratima Kunwar 1,7, Natalie Hawkins 2, Warren L. Dinges 1,3, Yi Liu 5, Erin E. Gabriel
More informationAn Evolutionary Story about HIV
An Evolutionary Story about HIV Charles Goodnight University of Vermont Based on Freeman and Herron Evolutionary Analysis The Aids Epidemic HIV has infected 60 million people. 1/3 have died so far Worst
More informationFinding protein sites where resistance has evolved
Finding protein sites where resistance has evolved The amino acid (Ka) and synonymous (Ks) substitution rates Please sit in row K or forward The Berlin patient: first person cured of HIV Contracted HIV
More informationHIV-1 SUBTYPE C MOTHER-TO-CHILD TRANSMISSION: GENETIC AND IMMUNOLOGIC CORRELATES. Elizabeth Susan Russell
HIV-1 SUBTYPE C MOTHER-TO-CHILD TRANSMISSION: GENETIC AND IMMUNOLOGIC CORRELATES Elizabeth Susan Russell A dissertation submitted to the faculty of the University of North Carolina at Chapel Hill in partial
More informationEMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV. (Summary of the recommendations from an Enterprise Working Group)
AIDS Vaccine 07, Seattle, August 20-23, 2007 EMERGING ISSUES IN THE HUMORAL IMMUNE RESPONSE TO HIV (Summary of the recommendations from an Enterprise Working Group) The Working Group Reston, Virginia,
More informationDistinguishing epidemiological dependent from treatment (resistance) dependent HIV mutations: Problem Statement
Distinguishing epidemiological dependent from treatment (resistance) dependent HIV mutations: Problem Statement Leander Schietgat 1, Kristof Theys 2, Jan Ramon 1, Hendrik Blockeel 1, and Anne-Mieke Vandamme
More informationVirological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication
Virological failure to Protease inhibitors in Monotherapy is linked to the presence of signature mutations in Gag without changes in HIV-1 replication Oscar Blanch-Lombarte Rome, 7-9 June, 2017 European
More informationDETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING. John Archer. Faculty of Life Sciences University of Manchester
DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING John Archer Faculty of Life Sciences University of Manchester HIV Dynamics and Evolution, 2008, Santa Fe, New Mexico. Overview
More informationIAS 2015 Towards an HIV Cure symposium Vancouver Immune recognition following latency reversal
IAS 2015 Towards an HIV Cure symposium Vancouver Immune recognition following latency reversal Marcus Altfeld Professor of Medicine Outline Immune recognition of HIV-1-infected cells Kinetics of antigen
More informationExploring HIV Evolution: An Opportunity for Research Sam Donovan and Anton E. Weisstein
Microbes Count! 137 Video IV: Reading the Code of Life Human Immunodeficiency Virus (HIV), like other retroviruses, has a much higher mutation rate than is typically found in organisms that do not go through
More informationA Path to an HIV Vaccine: GSID Consortium Activities. Faruk Sinangil, PhD 4th Annual CAVD Meeting Miami, FL December 1-4, 2009
A Path to an HIV Vaccine: GSID Consortium Activities Faruk Sinangil, PhD 4th Annual CAVD Meeting Miami, FL December 1-4, 2009 Project Goals Acquire and disseminate information that will contribute to the
More informationIncreased sequence coverage through combined targeting of variant. and conserved epitopes correlates with control of HIV replication
JVI Accepts, published online ahead of print on 13 November 2013 J. Virol. doi:10.1128/jvi.02361-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 Increased sequence coverage
More informationSingle genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope
Evering et al. Retrovirology 2014, 11:65 RESEARCH Open Access Single genome analysis reveals genetic characteristics of Neuroadaptation across HIV-1 envelope Teresa H Evering 1*, Edwin Kamau 2, Leslie
More informationDeep-Sequencing of HIV-1
Deep-Sequencing of HIV-1 The quest for true variants Alexander Thielen, Martin Däumer 09.05.2015 Limitations of drug resistance testing by standard-sequencing Blood plasma RNA extraction RNA Reverse Transcription/
More informationSynonymous Substitution Rates Predict HIV Disease Progression as a Result of Underlying Replication Dynamics
Synonymous Substitution Rates Predict HIV Disease Progression as a Result of Underlying Replication Dynamics Philippe Lemey 1*, Sergei L. Kosakovsky Pond 2, Alexei J. Drummond 3, Oliver G. Pybus 1, Beth
More informationLongitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants
This manuscript is currently under consideration for publication in Viruses http://www.mdpi.com/journal/viruses Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies
More informationSocio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania
Socio-Demographic Factors associated with Success of Antiretroviral Treatment among HIV Patients in Tanzania Dr. Fausta Franklin Mosha (MD, MSc, MSc, PHD) Ministry of Health and Social Welfare 22 nd October
More informationEstimating the mutational fitness effects distribution during early HIV infection
Virus Evolution, 2018, 4(2): vey029 doi: 10.1093/ve/vey029 Research article Estimating the mutational fitness effects distribution during early HIV infection Eva Bons 1, *,, Frederic Bertels 1,2, and Roland
More informationIrina Maljkovic Berry
Thesis for doctoral degree (Ph.D.) 2008 Thesis for doctoral degree (Ph.D.) 2008 Genetic aspects of HIV-1 evolution and transmission Irina Maljkovic Berry Genetic aspects of HIV-1 evolution and transmission
More informationIt is well known that some pathogenic microbes undergo
Colloquium Effects of passage history and sampling bias on phylogenetic reconstruction of human influenza A evolution Robin M. Bush, Catherine B. Smith, Nancy J. Cox, and Walter M. Fitch Department of
More informationImmune pressure analysis of protease and reverse transcriptase genes of primary HIV-1 subtype C isolates from South Africa
African Journal of Biotechnology Vol. 10(24), pp. 4784-4793, 6 June, 2011 Available online at http://www.academicjournals.org/ajb DOI: 10.5897/AJB10.560 ISSN 1684 5315 2011 Academic Journals Full Length
More informationReceived 4 August 2005/Accepted 7 December 2005
JOURNAL OF VIROLOGY, Mar. 2006, p. 2472 2482 Vol. 80, No. 5 0022-538X/06/$08.00 0 doi:10.1128/jvi.80.5.2472 2482.2006 Copyright 2006, American Society for Microbiology. All Rights Reserved. Extensive Recombination
More informationHigh Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1635 1641 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.01478-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. High Failure
More informationDefining kinetic properties of HIV-specific CD8 + T-cell responses in acute infection
Defining kinetic properties of HIV-specific CD8 + T-cell responses in acute infection Yiding Yang 1 and Vitaly V. Ganusov 1,2,3 1 Department of Microbiology, University of Tennessee, Knoxville, TN 37996,
More informationDid the surgeon give hepatitis C to his patient?
ForensicEA Lite Tutorial Did the surgeon give hepatitis C to his patient? In a recent issue of the Journal of Medical Virology, R. Stephan Ross and colleagues (2002) report the story of a German surgeon
More informationFrom Mosquitos to Humans: Genetic evolution of Zika Virus
Article: From Mosquitos to Humans: Genetic evolution of Zika Virus Renata Pellegrino, PhD Director, Sequencing lab Center for Applied Genomics The Children s Hospital of Philadelphia Journal Club Clinical
More informationANALYSIS OF HOST AND VIRAL FACTORS IN THE ELITE SUPPRESSION OF HIV-1 INFECTION. Robert W. Buckheit III
ANALYSIS OF HOST AND VIRAL FACTORS IN THE ELITE SUPPRESSION OF HIV-1 INFECTION By Robert W. Buckheit III A dissertation submitted to Johns Hopkins University in conformity with the requirements for the
More informationRapid intrahost evolution of human cytomegalovirus is shaped by demography and positive selection
University of Massachusetts Medical School escholarship@umms Open Access Articles Open Access Publications by UMMS Authors 9-26-2013 Rapid intrahost evolution of human cytomegalovirus is shaped by demography
More informationHIV and Challenges of Vaccine Development
Dale and Betty Bumpers Vaccine Research Center National Institute of Allergy and Infectious Diseases National Institutes of Health HIV and Challenges of Vaccine Development Richard A. Koup, MD INTEREST
More informationTITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important?
TITLE: Influenza A (H7N9) virus evolution: Which genetic mutations are antigenically important? AUTHORS: Joshua G. Petrie 1, Adam S. Lauring 2,3 AFFILIATIONS: 1 Department of Epidemiology, University of
More information